Yale researchers have found a new treatment pathway for aggressive leukemia, according to an announcement from the university.

By analyzing clinical data from patients with leukemia and studying surface receptor CD25, the researchers found that “leukemia cells express CD25 on the cell surface to assemble a protein complex that dampens activity and makes cancer cells grow at a slower, steadier pace.” Therefore, scientists should look to treatments that “target CD25 and associated proteins.”